☰

Kimberly M. Sogi, Ph.D. - Publications

Affiliations: 
2012 Chemistry University of California, Berkeley, Berkeley, CA, United States 
Area:
Bioorthogonal chemistry
Tree Info Similar researchers PubMed Report error

9 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Van Dis E, Sogi KM, Rae CS, Sivick KE, Surh NH, Leong ML, Kanne DB, Metchette K, Leong JJ, Bruml JR, Chen V, Heydari K, Cadieux N, Evans T, McWhirter SM, et al. STING-Activating Adjuvants Elicit a Th17 Immune Response and Protect against Mycobacterium tuberculosis Infection. Cell Reports. 23: 1435-1447. PMID 29719256 DOI: 10.1016/J.Celrep.2018.04.003  0.355
2017 Sogi KM, Lien KA, Johnson J, Krogan NJ, Stanley S. The tyrosine kinase inhibitor gefitinib restricts Mycobacterium tuberculosis growth through increased lysosomal biogenesis and modulation of cytokine signaling. Acs Infectious Diseases. PMID 28537707 DOI: 10.1021/Acsinfecdis.7B00046  0.541
2016 Sogi KM, Holsclaw CM, Fragiadakis GK, Nomura DK, Leary JA, Bertozzi CR. Biosynthesis and Regulation of Sulfomenaquinone, a Metabolite Associated with Virulence in Mycobacterium tuberculosis. Acs Infectious Diseases. 2: 800-806. PMID 27933784 DOI: 10.1021/Acsinfecdis.6B00106  0.678
2016 Braverman J, Sogi KM, Benjamin D, Nomura DK, Stanley SA. HIF-1α Is an Essential Mediator of IFN-γ-Dependent Immunity to Mycobacterium tuberculosis. Journal of Immunology (Baltimore, Md. : 1950). PMID 27430718 DOI: 10.4049/Jimmunol.1600266  0.422
2014 Stanley SA, Barczak AK, Silvis MR, Luo SS, Sogi K, Vokes M, Bray MA, Carpenter AE, Moore CB, Siddiqi N, Rubin EJ, Hung DT. Identification of host-targeted small molecules that restrict intracellular Mycobacterium tuberculosis growth. Plos Pathogens. 10: e1003946. PMID 24586159 DOI: 10.1371/Journal.Ppat.1003946  0.493
2013 Sogi KM, Gartner ZJ, Breidenbach MA, Appel MJ, Schelle MW, Bertozzi CR. Mycobacterium tuberculosis Rv3406 is a type II alkyl sulfatase capable of sulfate scavenging. Plos One. 8: e65080. PMID 23762287 DOI: 10.1371/Journal.Pone.0065080  0.59
2012 Seeliger JC, Topp S, Sogi KM, Previti ML, Gallivan JP, Bertozzi CR. A riboswitch-based inducible gene expression system for mycobacteria. Plos One. 7: e29266. PMID 22279533 DOI: 10.1371/Journal.Pone.0029266  0.469
2011 Hatzios SK, Schelle MW, Newton GL, Sogi KM, Holsclaw CM, Fahey RC, Bertozzi CR. The Mycobacterium tuberculosis CysQ phosphatase modulates the biosynthesis of sulfated glycolipids and bacterial growth. Bioorganic & Medicinal Chemistry Letters. 21: 4956-9. PMID 21795043 DOI: 10.1016/J.Bmcl.2011.06.057  0.59
2008 Holsclaw CM, Sogi KM, Gilmore SA, Schelle MW, Leavell MD, Bertozzi CR, Leary JA. Structural characterization of a novel sulfated menaquinone produced by stf3 from Mycobacterium tuberculosis. Acs Chemical Biology. 3: 619-24. PMID 18928249 DOI: 10.1021/Cb800145R  0.649
Show low-probability matches.